Table 2.
Events/total | Model 1 | Model 2 | Model 3 | ||||||
---|---|---|---|---|---|---|---|---|---|
Effect size (95% CI) |
P value | Effect size (95% CI) |
P value | Effect size (95% CI) |
P value | ||||
In-hospital mortality | |||||||||
< 0.50 | 36/286 | 1.71 (1.17 − 2.48) | 0.005 | 1.87 (1.28 − 2.73) | 0.001 | 1.56 (1.04 − 2.35) | 0.033 | ||
0.50–0.74 | 107/1018 | 1.39 (1.09–1.77) | 0.007 | 1.42 (1.11–1.81) | 0.005 | 1.33 (1.03–1.71) | 0.029 | ||
0.75–0.99 | 222/2854 | Ref | – | Ref | – | Ref | – | ||
1.00–1.24 | 165/1904 | 1.12 (0.91–1.39) | 0.273 | 1.13 (0.91–1.39) | 0.272 | 1.10 (0.89–1.36) | 0.378 | ||
1.25–1.49 | 103/996 | 1.37 (1.07–1.75) | 0.013 | 1.37 (1.07–1.75) | 0.012 | 1.34 (1.04–1.72) | 0.024 | ||
1.50–1.74 | 59/530 | 1.49 (1.10 − 2.01) | 0.011 | 1.52 (1.12 − 2.06) | 0.007 | 1.41 (1.03–1.94) | 0.030 | ||
≥ 1.75 | 100/680 | 2.04 (1.59 − 2.63) | < 0.001 | 1.87 (1.28 − 2.73) | < 0.001 | 1.93 (1.48 − 2.52) | < 0.001 | ||
One-year mortality | |||||||||
< 0.50 | 160/286 | 2.19 (1.71 − 2.80) | < 0.001 | 2.70 (2.10–3.48) | < 0.001 | 1.69 (1.28 − 2.24) | < 0.001 | ||
0.50–0.74 | 483/1018 | 1.56 (1.35–1.80) | < 0.001 | 1.65 (1.42–1.92) | < 0.001 | 1.37 (1.17–1.61) | < 0.001 | ||
0.75–0.99 | 1047/2854 | Ref | – | Ref | – | Ref | – | ||
1.00–1.24 | 719/1904 | 1.05 (0.93–1.18) | 0.451 | 1.05 (0.93–1.19) | 0.450 | 1.00 (0.87–1.13) | 0.946 | ||
1.25–1.49 | 414/996 | 1.23 (1.06–1.42) | 0.006 | 1.24 (1.06–1.44) | 0.006 | 1.16 (0.99–1.36) | 0.075 | ||
1.50–1.74 | 236/530 | 1.39 (1.15–1.67) | 0.001 | 1.45 (1.20–1.76) | < 0.001 | 1.24 (1.01–1.52) | 0.042 | ||
≥ 1.75 | 346/680 | 1.79 (1.51 − 2.12) | < 0.001 | 2.00 (1.68 − 2.39) | < 0.001 | 1.64 (1.36–1.97) | < 0.001 |
Model 1: unadjusted model; Model 2: adjusted by age and sex; Model 3: adjusted by age, sex, urine output, hypertension, DM, AF, acute HF, MI, OMI, stroke, non-ischemic cardiomyopathy, CKD, Nt-pro BNP, SCr, BUN, HbA1c, history of insulin use, vasopressors, loop diuretics, MV, and RRT.